Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
109
2.910
 Why?
Ophthalmologic Surgical Procedures
5
2017
57
2.150
 Why?
Angiogenesis Inhibitors
11
2022
219
1.970
 Why?
Retina
11
2016
279
1.700
 Why?
Glaucoma
4
2017
221
1.580
 Why?
Eye Foreign Bodies
5
2016
25
1.560
 Why?
Alloys
4
2013
34
1.560
 Why?
Macular Edema
4
2022
43
1.520
 Why?
Retinal Detachment
6
2019
58
1.490
 Why?
Vitrectomy
7
2019
66
1.450
 Why?
Diabetic Retinopathy
6
2019
178
1.410
 Why?
Glaucoma Drainage Implants
3
2016
46
1.380
 Why?
Retinal Diseases
5
2017
87
1.220
 Why?
Intraocular Pressure
7
2017
299
1.200
 Why?
Nanopores
2
2020
7
1.180
 Why?
Intravitreal Injections
7
2022
56
1.150
 Why?
Membranes, Artificial
2
2020
71
1.150
 Why?
Nanotechnology
2
2020
121
1.080
 Why?
Suction
3
2015
32
1.000
 Why?
Sutures
3
2015
53
0.950
 Why?
Anterior Eye Segment
2
2017
9
0.930
 Why?
Choroidal Neovascularization
4
2011
55
0.930
 Why?
Swine
10
2017
764
0.920
 Why?
Suture Techniques
3
2015
118
0.920
 Why?
Equipment Design
6
2017
514
0.890
 Why?
Lens Implantation, Intraocular
2
2015
59
0.860
 Why?
Retinitis
1
2022
20
0.790
 Why?
Retinal Vasculitis
1
2022
10
0.790
 Why?
Aneurysm
1
2022
31
0.780
 Why?
Vitreoretinopathy, Proliferative
2
2019
14
0.720
 Why?
Antibodies, Monoclonal
6
2020
1366
0.720
 Why?
Vascular Endothelial Growth Factor A
6
2020
530
0.710
 Why?
Durapatite
1
2020
34
0.680
 Why?
Retinal Vessels
2
2015
65
0.680
 Why?
Cytomegalovirus Retinitis
2
2013
18
0.670
 Why?
Isoxazoles
2
2013
54
0.660
 Why?
Complement System Proteins
2
2020
318
0.660
 Why?
Eye Injuries, Penetrating
3
2016
19
0.660
 Why?
Scleral Buckling
3
2012
18
0.660
 Why?
Endophthalmitis
2
2017
28
0.660
 Why?
Immunosuppressive Agents
3
2013
858
0.650
 Why?
Disease Models, Animal
8
2020
4078
0.650
 Why?
Stents
2
2013
504
0.610
 Why?
Fluorocarbons
2
2012
109
0.570
 Why?
Anterior Chamber
1
2017
22
0.550
 Why?
Glucocorticoids
2
2020
580
0.550
 Why?
Transducers
1
2017
27
0.550
 Why?
Strabismus
1
2017
28
0.540
 Why?
Sclera
2
2015
36
0.520
 Why?
Filtering Surgery
1
2016
22
0.520
 Why?
Trabeculectomy
1
2017
72
0.510
 Why?
Surgical Instruments
2
2013
51
0.510
 Why?
Fovea Centralis
2
2006
11
0.500
 Why?
Retinal Perforations
2
2005
13
0.500
 Why?
Drug Resistance, Multiple, Viral
2
2013
11
0.490
 Why?
Ocular Hypertension
1
2016
67
0.490
 Why?
Ophthalmology
2
2013
82
0.490
 Why?
Laser Therapy
1
2017
129
0.480
 Why?
Lenses, Intraocular
1
2015
43
0.480
 Why?
Monitoring, Physiologic
1
2017
265
0.480
 Why?
Lasers
1
2015
132
0.470
 Why?
Device Removal
1
2016
136
0.460
 Why?
Prostheses and Implants
1
2016
135
0.460
 Why?
Tomography, Optical Coherence
7
2015
186
0.450
 Why?
Antiviral Agents
2
2013
715
0.440
 Why?
Ischemia
2
2017
406
0.440
 Why?
Fluorescein Angiography
9
2012
143
0.430
 Why?
Models, Cardiovascular
1
2015
191
0.430
 Why?
Rabbits
3
2020
779
0.430
 Why?
Retinal Degeneration
2
2015
34
0.420
 Why?
Artificial Lens Implant Migration
1
2013
3
0.420
 Why?
Animals
18
2020
35391
0.410
 Why?
Choroid
3
2015
62
0.410
 Why?
Macular Degeneration
6
2015
159
0.410
 Why?
Viscosupplements
1
2012
11
0.410
 Why?
Gravitation
1
2012
15
0.410
 Why?
Silicone Oils
1
2012
26
0.400
 Why?
Silicon
1
2012
14
0.400
 Why?
Pupil Disorders
1
2012
5
0.400
 Why?
Eye Enucleation
1
2012
11
0.400
 Why?
Iris
1
2012
19
0.400
 Why?
Viremia
1
2013
131
0.390
 Why?
Quantum Dots
1
2012
34
0.390
 Why?
Silicone Elastomers
1
2012
7
0.390
 Why?
Uveitis, Posterior
1
2012
12
0.380
 Why?
Prosthesis Implantation
1
2013
146
0.380
 Why?
Surgical Stapling
1
2012
14
0.380
 Why?
Fluocinolone Acetonide
1
2012
19
0.380
 Why?
Vitreous Hemorrhage
2
2015
5
0.380
 Why?
Electric Stimulation Therapy
1
2012
77
0.370
 Why?
Cataract Extraction
1
2013
97
0.370
 Why?
Models, Biological
4
2015
1724
0.370
 Why?
Vascular Endothelial Growth Factors
1
2011
78
0.360
 Why?
Materials Testing
1
2012
342
0.340
 Why?
Cytomegalovirus
2
2013
154
0.330
 Why?
Oxygen
1
2015
915
0.330
 Why?
Humans
47
2022
129625
0.320
 Why?
Anti-Inflammatory Agents
1
2012
482
0.290
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
254
0.290
 Why?
Biocompatible Materials
1
2012
392
0.290
 Why?
Electroretinography
5
2016
45
0.280
 Why?
von Hippel-Lindau Disease
1
2007
12
0.270
 Why?
Injections
5
2012
174
0.270
 Why?
Pigment Epithelium of Eye
2
2006
35
0.270
 Why?
Puerperal Disorders
1
2007
31
0.270
 Why?
Recombinant Fusion Proteins
4
2022
651
0.260
 Why?
Drug Implants
2
2020
82
0.260
 Why?
Uveal Diseases
1
2006
5
0.260
 Why?
Ocular Hypotension
1
2006
10
0.260
 Why?
Antibodies, Monoclonal, Humanized
6
2015
757
0.260
 Why?
Fusobacterium Infections
1
2006
7
0.250
 Why?
Pharyngeal Diseases
1
2006
15
0.250
 Why?
Needles
2
2017
57
0.250
 Why?
Epiretinal Membrane
1
2005
7
0.250
 Why?
Ciliary Body
1
2006
33
0.250
 Why?
Telangiectasis
1
2005
6
0.250
 Why?
Visual Acuity
7
2019
327
0.240
 Why?
Dementia
2
2022
225
0.240
 Why?
Rats, Inbred BN
3
2011
59
0.240
 Why?
Uveitis
1
2006
127
0.240
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
107
0.240
 Why?
Female
26
2022
68734
0.230
 Why?
Kidney Transplantation
2
2013
670
0.230
 Why?
Injections, Intraocular
2
2015
10
0.230
 Why?
Polypropylenes
2
2015
14
0.220
 Why?
Middle Aged
17
2019
31136
0.210
 Why?
Laser Coagulation
3
2012
57
0.200
 Why?
Bevacizumab
6
2015
128
0.200
 Why?
Autoimmune Diseases
1
2006
427
0.200
 Why?
Optic Atrophy
1
2022
10
0.200
 Why?
Hearing Loss, Central
1
2022
5
0.200
 Why?
Retinal Vein Occlusion
2
2015
13
0.180
 Why?
Cell Count
2
2012
312
0.180
 Why?
Rats
4
2012
5483
0.180
 Why?
Dialysis
1
2020
18
0.170
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.170
 Why?
Orbital Neoplasms
1
2000
21
0.170
 Why?
Time Factors
4
2017
6555
0.170
 Why?
Adsorption
1
2020
139
0.170
 Why?
Follow-Up Studies
5
2015
4894
0.160
 Why?
Male
21
2019
63670
0.160
 Why?
Adult
11
2022
35599
0.160
 Why?
Biomarkers
2
2020
3968
0.150
 Why?
Wet Macular Degeneration
1
2019
46
0.150
 Why?
Fluorescein-5-isothiocyanate
2
2009
37
0.150
 Why?
Eye Diseases, Hereditary
1
2018
11
0.150
 Why?
Geographic Atrophy
1
2019
69
0.150
 Why?
Miniaturization
2
2015
23
0.150
 Why?
Dextrans
2
2009
84
0.140
 Why?
Iris Diseases
1
2017
6
0.140
 Why?
Choroid Diseases
1
2017
10
0.140
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
14
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
834
0.140
 Why?
Dark Adaptation
2
2012
14
0.140
 Why?
Hypertension
1
2006
1243
0.130
 Why?
Antimony
1
2016
5
0.130
 Why?
Infliximab
2
2007
101
0.130
 Why?
Aged, 80 and over
6
2019
7052
0.130
 Why?
Dose-Response Relationship, Drug
3
2014
2011
0.130
 Why?
Polymers
1
2020
477
0.130
 Why?
Pressure
1
2017
237
0.130
 Why?
Sclerostomy
1
2015
4
0.130
 Why?
Foreign-Body Migration
1
2016
34
0.120
 Why?
Treatment Outcome
9
2016
10219
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.120
 Why?
Aged
10
2020
22061
0.120
 Why?
Vitreoretinal Surgery
1
2015
3
0.120
 Why?
Eye Infections, Bacterial
1
2015
27
0.120
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
38
0.120
 Why?
Stress, Mechanical
1
2017
467
0.120
 Why?
Equipment Failure Analysis
1
2015
130
0.120
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1280
0.120
 Why?
Vitreous Detachment
1
2015
9
0.120
 Why?
Partial Pressure
1
2015
29
0.120
 Why?
Hemoglobin SC Disease
1
2015
13
0.120
 Why?
Prosthesis Failure
1
2016
114
0.120
 Why?
Biopsy, Needle
1
2015
188
0.120
 Why?
Feedback
1
2015
162
0.120
 Why?
Oculomotor Muscles
1
2014
38
0.120
 Why?
International Normalized Ratio
1
2014
46
0.110
 Why?
Protein Binding
1
2020
2124
0.110
 Why?
Postoperative Care
1
2015
241
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
14
0.110
 Why?
Down Syndrome
1
2000
477
0.110
 Why?
Retinal Artery Occlusion
1
2013
8
0.110
 Why?
Tendons
1
2014
106
0.110
 Why?
In Vitro Techniques
1
2015
1087
0.110
 Why?
Warfarin
1
2014
147
0.110
 Why?
Specific Gravity
1
2012
11
0.100
 Why?
Transducers, Pressure
1
2012
13
0.100
 Why?
Diabetes Mellitus, Type 2
2
2012
2442
0.100
 Why?
Erythrocyte Transfusion
1
2015
181
0.100
 Why?
Metabolomics
1
2018
653
0.100
 Why?
Research Design
1
2019
1045
0.100
 Why?
Adaptation, Ocular
1
2012
4
0.100
 Why?
Rats, Mutant Strains
1
2012
24
0.100
 Why?
Minerals
1
2012
39
0.100
 Why?
Pupil
1
2012
13
0.100
 Why?
Viscosity
1
2012
90
0.100
 Why?
Antineoplastic Agents
2
2020
2046
0.100
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.100
 Why?
Acetates
1
2012
100
0.100
 Why?
Sodium Chloride
1
2012
137
0.100
 Why?
Endothelium, Corneal
1
2012
16
0.100
 Why?
Retinal Neovascularization
1
2012
25
0.100
 Why?
Tumor Necrosis Factor-alpha
2
2007
1202
0.090
 Why?
Electrodes, Implanted
1
2012
106
0.090
 Why?
Swine, Miniature
1
2012
81
0.090
 Why?
Microsurgery
1
2012
70
0.090
 Why?
Drug Combinations
1
2012
331
0.090
 Why?
Retinal Ganglion Cells
1
2012
101
0.090
 Why?
Adolescent
4
2019
20412
0.090
 Why?
Bruch Membrane
1
2011
6
0.090
 Why?
Gold
1
2012
118
0.090
 Why?
Polyglycolic Acid
1
2011
39
0.090
 Why?
Registries
1
2019
1899
0.090
 Why?
Administration, Oral
1
2013
787
0.090
 Why?
Drug Compounding
1
2011
97
0.090
 Why?
Dissection
1
2011
51
0.090
 Why?
Computer Simulation
1
2015
939
0.090
 Why?
Delayed-Action Preparations
1
2011
172
0.080
 Why?
Models, Animal
1
2012
378
0.080
 Why?
Atrial Fibrillation
1
2014
376
0.080
 Why?
Anemia, Sickle Cell
1
2013
252
0.080
 Why?
Retrospective Studies
8
2015
14522
0.080
 Why?
Lactic Acid
1
2011
298
0.080
 Why?
Cell Survival
1
2012
1076
0.080
 Why?
Bacteria
1
2015
814
0.080
 Why?
Scotoma
1
2008
5
0.070
 Why?
Proliferating Cell Nuclear Antigen
1
2007
53
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
30
0.070
 Why?
Severity of Illness Index
2
2014
2739
0.070
 Why?
Papilledema
1
2007
39
0.070
 Why?
Pilot Projects
1
2012
1592
0.070
 Why?
Visual Fields
3
2007
87
0.070
 Why?
RNA, Catalytic
1
2007
185
0.070
 Why?
Retinitis Pigmentosa
1
2006
20
0.060
 Why?
Glycogen Storage Disease Type IIb
1
2006
25
0.060
 Why?
Triamcinolone Acetonide
1
2006
27
0.060
 Why?
Fusobacterium necrophorum
1
2006
2
0.060
 Why?
Polyethylene Glycols
1
2011
589
0.060
 Why?
Indocyanine Green
1
2005
19
0.060
 Why?
Vision, Low
3
2013
16
0.060
 Why?
Myopia
1
2006
47
0.060
 Why?
Coloring Agents
1
2005
77
0.060
 Why?
Eye Injuries
1
2006
46
0.060
 Why?
Infusions, Intravenous
1
2006
399
0.060
 Why?
Young Adult
2
2019
12455
0.060
 Why?
Staining and Labeling
1
2005
142
0.060
 Why?
Syndrome
1
2006
340
0.060
 Why?
Cataract
1
2006
209
0.050
 Why?
Multivariate Analysis
2
2019
1499
0.050
 Why?
Diagnosis, Differential
1
2007
1432
0.050
 Why?
Ranibizumab
2
2013
20
0.050
 Why?
Blindness
2
2013
38
0.050
 Why?
Keratitis
1
2000
14
0.040
 Why?
Postoperative Complications
1
2012
2477
0.040
 Why?
Exophthalmos
1
2000
17
0.040
 Why?
Chronic Disease
1
2006
1720
0.040
 Why?
Immunophenotyping
1
2000
311
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2512
0.040
 Why?
Xanthine
1
2018
7
0.040
 Why?
Combined Modality Therapy
2
2013
1203
0.040
 Why?
Electrooculography
1
1997
12
0.030
 Why?
Visual Field Tests
1
1997
16
0.030
 Why?
Color Vision Defects
1
1997
7
0.030
 Why?
Fundus Oculi
1
1997
61
0.030
 Why?
Purines
1
2018
172
0.030
 Why?
Cohort Studies
2
2019
5426
0.030
 Why?
Odds Ratio
1
2019
1019
0.030
 Why?
Photic Stimulation
1
1997
241
0.030
 Why?
Child
2
2015
20884
0.030
 Why?
Vision Disorders
1
1997
135
0.030
 Why?
Microbiological Techniques
1
2015
30
0.030
 Why?
Endotamponade
1
2015
2
0.030
 Why?
Colony Count, Microbial
1
2015
117
0.030
 Why?
Myopia, Degenerative
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
30
0.030
 Why?
Metabolome
1
2018
340
0.030
 Why?
Photography
1
2015
93
0.030
 Why?
Mass Spectrometry
1
2018
714
0.030
 Why?
Atrophy
1
2015
169
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Biometry
1
2014
69
0.030
 Why?
Disease Progression
2
2015
2627
0.030
 Why?
Pregnancy
1
2007
6417
0.030
 Why?
Glucose
1
2018
1002
0.030
 Why?
Risk Factors
2
2019
9786
0.030
 Why?
Fatty Acids, Omega-3
1
2014
138
0.020
 Why?
Risk Assessment
2
2014
3262
0.020
 Why?
Retreatment
1
2012
70
0.020
 Why?
Kaplan-Meier Estimate
1
2014
851
0.020
 Why?
Oxidative Stress
1
2018
1266
0.020
 Why?
Global Health
1
2014
328
0.020
 Why?
Survival Analysis
1
2014
1269
0.020
 Why?
Proportional Hazards Models
1
2014
1198
0.020
 Why?
Health Care Costs
1
2014
367
0.020
 Why?
Phenotype
1
2019
3075
0.020
 Why?
Antioxidants
1
2014
558
0.020
 Why?
Anticoagulants
1
2014
637
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
430
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
72
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
51
0.020
 Why?
Comorbidity
1
2014
1547
0.020
 Why?
Colorado
1
2019
4404
0.020
 Why?
Prospective Studies
2
2012
7135
0.020
 Why?
Retinal Artery
1
2007
16
0.020
 Why?
Cerebral Angiography
1
2007
108
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
28
0.020
 Why?
Infant
1
2000
8995
0.020
 Why?
Frameshift Mutation
1
2006
32
0.020
 Why?
Secondary Prevention
1
2007
219
0.020
 Why?
Prognosis
1
2014
3774
0.020
 Why?
Anti-Bacterial Agents
1
2015
1705
0.010
 Why?
Adrenal Cortex Hormones
1
2008
524
0.010
 Why?
Double-Blind Method
1
2007
1875
0.010
 Why?
RNA, Messenger
1
2007
2708
0.010
 Why?
Aging
1
2008
1778
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)